Connection
Matthew Wortham to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Matthew Wortham has written about Non-alcoholic Fatty Liver Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.159 |
|
|
|
-
Ramms B, Pollow DP, Zhu H, Nora C, Harrington AR, Omar I, Gordts PLSM, Wortham M, Sander M. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes. 2022 12 01; 71(12):2513-2529.
Score: 0.159